Press releases

Month Year

Email alerts

Dec 21, 2010

Landmark Medtronic CoreValve(R) U.S. Clinical Trial Begins

Investigational Therapy Offers Treatment Alternative to Open Heart-Surgery for Patients with Severe Aortic Stenosis

MINNEAPOLIS, Dec 21, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the beginning of its Medtronic CoreValve(R) U.S. Pivotal clinical trial in the United States. The first...
Dec 20, 2010

Medtronic Announces Chairman and CEO William A. Hawkins to Retire at End of Company's Current Fiscal Year

MINNEAPOLIS, Dec 20, 2010 (BUSINESS WIRE) -- Medtronic (NYSE:MDT) announced today that William A. Hawkins intends to retire as Chairman and CEO of Medtronic at the conclusion of the current fiscal...
Dec 17, 2010

Medtronic Receives FDA Approval for First and Only Cryoballoon Ablation Treatment in the U.S. for Paroxysmal Atrial Fibrillation

New Arctic Front(R) Cardiac CryoAblation Catheter System Reduces Symptoms for Patients with Common Heart Rhythm Disorder

MINNEAPOLIS, Dec 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic Front(R) Cardiac CryoAblation...
Dec 9, 2010

Medtronic CoreValve(R) System Gains CE Mark for New Subclavian Approach to Transcatheter Aortic Valve Implantation

Approval is Expected to Expand Access to Care for Patients with Severe Aortic Stenosis

MINNEAPOLIS, Dec 09, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) has received CE (Conformité Européenne) Mark for the Medtronic CoreValve(R) System to be delivered through a novel...
Dec 9, 2010

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2011

MINNEAPOLIS, Dec 09, 2010 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock. The dividend is...

Show per page